The global azathioprine tablets market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Azathioprine is an immunosuppressive drug that is majorly marketed under the brand name of Imuran among others. It is used totreat diseases such as rheumatoid arthritis, granulomatosis with polyangiitis, ulcerative colitis, Crohn’s disease, and kidney transplants to prevent organ rejection. Thus, the rising prevalence of arthritis, rheumatoid arthritis, osteoarthritis, and others is anticipated to drive the azathioprine market across the globe. According to the Centers for Disease Control and Prevention (CDC), approximately 24% of the adults out of the total US population are suffering with arthritis. In addition, the US population is spending more than $303.5 billion for the treatment and medical care of the arthritis annually.
Some major players in the azathioprine tablets market include Zydus Pharmaceuticals Inc., Mylan N.V., Amneal Pharmaceuticals, Inc., Sinopharm Group Co., Ltd., Teva Pharmaceutical Industries Ltd., among others. The market players are serving significantly in the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, in order to stay competitive in the market. For instance, in June 2021, the European Medicine Agency approved the prescripton of Jayempi. Jayempi is a hybrid medicine that comprises active susbstaces of azathioprine. It is an immunosuppressant medicine used to treat diseases including dermatomyositis, autoimmune hepatitis, severe rheumatoid arthritis, systemic lupus erythematosus, polyarteritis nodosa, and others. Currently, The reference medicine for Jayempi is Imurek and is available as tablets, while Jayempi is available as a liquid to be taken by mouth.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Azathioprine Tablets Market at https://orionmarketreports.com/request-sample/?id=92683&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Application
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Zydus Pharmaceuticals Inc., Mylan N.V., Amneal Pharmaceuticals, Inc., Sinopharm Group Co., Ltd., Teva Pharmaceutical Industries Ltd., among others.
A full report is available at: https://orionmarketreports.com/global-azathioprine-tablets-market/92683/
Global Azathioprine Tablets Market Report by Segment
By Type
- 25mg
- 50mg
- 100mg
By Application
- Transplantation
- Auto-Immune Diseases
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
